Results 1 to 10 of about 8,668 (192)
Dyshidrosiform Bullous Pemphigoid [PDF]
Medicina, 2021 Dyshidrosiform bullous pemphigoid is a variant of bullous pemphigoid. At least 84 patients with dyshidrosiform bullous pemphigoid have been described. Dyshidrosiform bullous pemphigoid usually presents with pruritic blisters in elderly individuals; the ...
Philip R. Cohen
doaj +3 more sources
Prevalence, Spectrum and Clinical Implications of Malignancies in Patients with Bullous Pemphigoid
Acta Dermato-Venereologica, 2023 Current research on the malignancy rate and spectrum of malignancies in patients with bullous pemphigoid is contradictory. The aims of this study were to determine the prevalence and spectrum of malignancy in patients with bullous pemphigoid and to ...
Sharon Baum +4 more
doaj +1 more source
Anais Brasileiros de Dermatologia, 2019 Bullous pemphigoid is the most frequent autoimmune bullous disease and mainly affects elderly individuals. Increase in incidence rates in the past decades has been attributed to population aging, drug-induced cases and improvement in the diagnosis of the nonbullous presentations of the disease. A dysregulated T cell immune response and synthesis of IgG
Denise Miyamoto +3 more
openaire +6 more sources
Case Reports in Dermatology, 2022 Bullous pemphigoid is the most common acquired bullous disease with an autoimmune basis and a tendency to involve mostly old people. By rising incidence of diabetes all over the world, consumption of antidiabetes medications has also increased.
Kamran Balighi +4 more
doaj +1 more source
Immunomodulator Galectin-9 is Increased in Blood and Skin of Patients with Bullous Pemphigoid
Acta Dermato-Venereologica, 2021 Massive recruitment of eosinophils into the dermis is a hallmark of bullous pemphigoid pathogenesis. Identifying the chemoattractant(s) guiding eosinophils into the skin in bullous pemphigoid is a prerequisite to therapeutic targeting of eosinophil ...
Jasper Pruessmann +8 more
doaj +1 more source
Comorbidity in bullous pemphigoid: up-date and clinical implications
Frontiers in Immunology, 2023 Bullous pemphigoid is the most common autoimmune blistering disease in industrialized countries and particularly affects the elderly. In this patient population, comorbid diseases are frequent and may complicate management and treatment of bullous ...
Johanna Huttelmaier +2 more
doaj +1 more source
BMC Endocrine Disorders, 2021 Background Bullous pemphigoid is the most common bullous chronic autoimmune skin disease. Recent studies have suggested dipeptidyl-peptidase 4 inhibitors as possible predisposing agents of bullous pemphigoid.
Vaia Lambadiari +10 more
doaj +1 more source
Risk of Serious Infections in Patients with Bullous Pemphigoid: A Population-based Cohort Study
Acta Dermato-Venereologica, 2023 Patients with bullous pemphigoid are susceptible to serious infections, which are the leading cause of death in these patients. The aims of this population-based cohort study were to investigate the incidence and spectrum of serious infections in ...
Tsung-Hsien Chang +4 more
doaj +1 more source
European Journal of Case Reports in Internal Medicine, 2022 Bullous pemphigoid is a rare autoimmune dermatologic disease that usually occurs in the elderly. Mucous membrane lesions occur in about 10–35% of patients and are almost always limited to the oral mucous membrane. Esophageal involvement is very rare (4% of cases) and usually presents with chest pain, dysphagia, and odynophagia, though patients are ...
Castelo Branco, Catarina +2 more
openaire +4 more sources
Bilateral localized bullous pemphigoid in a young adult patient: A case report
SAGE Open Medical Case Reports, 2023 Bullous pemphigoid is the most common autoimmune subepidermal blistering disease, which typically presents in the elderly. Localized bullous pemphigoid is a rare variant of bullous pemphigoid, with only about 100 cases reported up to date. In this report,
Pedram Nourmohammadpour +5 more
doaj +1 more source